Medpace Holdings revenue and financials

MEDP · NASDAQ · USD

$602.90Change from previous close: −2.84%Absolute change: −$17.61

Close · October 6, 2026

In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.

Annual revenue · 2025: $2.53B
  1. $421.58M2016
  2. $436.15M2017
  3. $704.59M2018
  4. $860.97M2019
  5. $925.93M2020
  6. $1.14B2021
  7. $1.46B2022
  8. $1.89B2023
  9. $2.11B2024
  10. $2.53B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+19.97%
2025 vs 2024
Net income growth
+11.56%
2025 vs 2024
Net margin
17.8%
2024: 19.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820182017
Total assets1,9752,1011,6571,3521,6601,3911,1431,005968951
Current assets9901,029594334691474317178178130
Cash and equivalents49766924528.3461278132—23.326.5
Receivables427321308265186—————
Net property, plant and equipment249252265249223—————
Goodwill662662662662662662662—661661
Other intangible assets33.434.435.838.041.4—————
Current liabilities1,3441,105925803557440343263257193
Accounts payable28.132.531.933.125.7—————
Long-term debt——————0.0—79.7205
Total debt114126142189——————
Total liabilities1,5161,2751,098966707585417406378447
Total equity (incl. minority)459826559386953—————
Retained earnings-4608.2-222-360235—————